Teresa Carrillo-Diaz
Las Palmas De Gran Canaria, CN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Using machine learning to define mepolizumab treatment response at 2 years in patients with chronic rhinosinusitis with nasal polyps.
Journal: Frontiers in allergy
Published: October 06, 2025
Determinants of Poor Health-Related Quality of Life in Patients With Food Allergy.
Journal: Allergy
Published: August 29, 2025
Determinants of Poor Health-Related Quality of Life in Patients With Food Allergy.
Journal: Allergy
Published: August 29, 2025
Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients.
Journal: Annals of medicine
Published: October 04, 2024
Human resources in the National Health System. Medical education. SESPAS Report 2024
Journal: Gaceta sanitaria
Published: August 31, 2023
Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps.
Journal: Biomedicines
Published: December 31, 2022
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.
Journal: Drugs
Published: October 21, 2021
REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.
Journal: Drugs
Published: August 20, 2021
Alpha-1 antitrypsin deficiency hidden in allegedly normal variants.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: June 21, 2021
Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites.
Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites.
Journal: Clinical and translational allergy
Published: July 13, 2018
Last Updated: 09/26/2026